AzTrials
AzTrials

CybersicknessGAZE-CSNCT07616596

Gaze Stabilization vs Oculomotor Exercises on Cybersickness in Computer Users

A study testing Gaze Stabilization Exercises and Oculomotor Exercises in people with Cybersickness and Motion Sickness, run by University of Faisalabad at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many people who use computers for long hours experience "cybersickness" (dizziness, nausea, blurred vision) because their eyes see movement on the screen but their body feels still. This study aims to see which type of eye and head exercises works best to fix this. Read more about this study

Who is it for?
Ages 18 to 45 years
What is being tested?
Gaze Stabilization Exercises and Oculomotor Exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 sitePakistan
Study dates
1 Jan 2026to 22 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Screen time > 6 hours per day
  • Computer usage history of at least 10 years
  • Complaints of vertigo, blurred vision, and nausea during computer usage
  • Positive Romberg's test
  • Abnormal VOR (4-6 lines lost on LogMAR scale)
  • SSQ score between 20 and 40

Who cannot join

  • Diagnosed vestibular disorders (e.g., BPPV, Meniere's)
  • History of falls in the past 6 months
  • Pregnancy
  • Any neurological or neurodegenerative disease
  • Use of walking aids
  • Severe visual impairments (worse than 6/12 on Snellen)

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • The University of Faisalabad

    Faisalābad, Punjab Province, 3800

Other trials in Pakistan

About this study

Official title: Effectiveness of Gaze Stabilization Exercises Versus Oculomotor Exercises on Cybersickness in Computer Users: A Randomized Clinical Trial

Many people who use computers for long hours experience "cybersickness" (dizziness, nausea, blurred vision) because their eyes see movement on the screen but their body feels still. This study aims to see which type of eye and head exercises works best to fix this. We will compare Gaze Stabilization Exercises (head movements) against Oculomotor Exercises (eye movements). Forty-six computer users will perform these exercises for 4 weeks. We will measure their dizziness, vision, and quality of life before, during, and after the treatment.

Read the detailed description

This is a single-blinded, randomized clinical trial. Participants (n=46) will be recruited from The University of Faisalabad. Inclusion criteria include screen time >6 hours/day, computer usage for at least 10 years, and a Simulator Sickness Questionnaire (SSQ) score between 20 and 40.

Group A (Intervention): Gaze Stabilization Exercises. Week 1: View X1 exercises. Week 2: View X2 exercises. Week 3: Gaze shift exercises. Week 4: Imaginary Target exercises. (3 sessions/week, 1 minute per exercise, 3 times each).

Group B (Active Comparator): Oculomotor Exercises. Week 1: Range exercises. Week 2: Saccadic exercises. Week 3: Pursuit exercises. Week 4: Vergence exercises. (3 sessions/week, 1 minute per exercise, 3 times each).

Outcomes: The primary outcome is the change in Dynamic Visual Acuity (LogMAR scale) and Cybersickness (SSQ score). The secondary outcome is Quality of Life (SF-36 questionnaire). Measurements will be taken at baseline, Week 2, and Week 4. Data will be analyzed using SPSS version 20.

Being tested
Gaze Stabilization Exercises, Oculomotor Exercises
Keywords
Gaze Stabilization Exercises, Oculomotor Exercises, Computer Users, Vestibulo-Ocular Reflex, Dynamic Visual Acuity, Physical Therapy
Medical subject headings
Motion Sickness, Vestibular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gaze Stabilization ExercisesBehavioural

    Week 1 - View X1: Patient sits upright. Target held at eye level 1 meter away. Patient turns head horizontally (left/right) or vertically (up/down) while keeping eyes fixed on target. Speed: slow (1Hz). Duration: 1 minute. Repetitions: 3 times per direction. Week 2 - View X2: Same as View X1 but head movement speed increased to 2Hz. Week 3 - Gaze Shift: Two targets placed 30 cm apart horizontally or vertically. Patient rotates head to face Target 1, then shifts gaze to Target 2 while continuing head rotation toward Target 2. Duration: 1 minute. Repetitions: 3 times. Week 4 - Imaginary Target: Patient fixates on a target (e.g., a sticker on wall). Closes eyes. Rotates head 30-45 degrees away from target. While eyes closed, patient imagines still looking at target. Opens eyes and checks if fixation is accurate. Duration: 1 minute. Repetitions: 3 times per direction. All exercises are performed under supervision for the first 3 sessions, then home-based with weekly follow-up calls.

  • Oculomotor ExercisesBehavioural

    Week 1 - Range Oculomotor Exercises: Eyes closed. Patient moves eyes slowly in horizontal (left-right), vertical (up-down), diagonal (top-left to bottom-right), and rotational (clockwise/counterclockwise) directions. Duration: 1 minute per direction. Repetitions: 3 times. Week 2 - Saccadic Exercises: Two stationary targets (e.g., two fingers) held 30 cm apart at eye level. Patient rapidly shifts gaze between targets without moving head. Duration: 1 minute. Repetitions: 3 times. Week 3 - Pursuit Exercises: A single target (e.g., pen) is moved slowly horizontally and vertically. Patient follows target smoothly with eyes only (head still). Speed: approx 20 degrees/second. Duration: 1 minute per direction. Repetitions: 3 times. Week 4 - Vergence Exercises: Target (e.g., pen) starts at 50 cm from patient's nose. Patient focuses on target as it is slowly moved toward nose to 5 cm (convergence), then back to 50 cm (divergence). Duration: 1 minute. Repetitions: 3 times under supervision.

Study groups in NCT07616596
Study groupRoleWhat they receive
Gaze Stabilization ExercisesExperimentalParticipants in this arm will receive Gaze Stabilization Exercises (GSE) for 4 weeks, 3 sessions per week. The protocol includes View X1, View X2, Gaze Shift, and Imaginary Target exercises. Each exercise is performed for 1 minute, repeated 3 times per session. Exercises target the vestibulo-ocular reflex (VOR) by coordinating head and eye movements to reduce sensory conflict.
Receives: Behavioral: Gaze Stabilization Exercises
Oculomotor Exercises GroupActive comparatorParticipants in this arm will receive Oculomotor Exercises for 4 weeks, 3 sessions per week. The protocol includes Range, Saccadic, Pursuit, and Vergence exercises. Each exercise is performed for 1 minute, repeated 3 times per session. Exercises target isolated eye movements without head motion to improve oculomotor control and reduce visual strain.
Receives: Behavioral: Oculomotor Exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Vestibulo-Ocular Reflex (VOR) Function

    Measured by Dynamic Visual Acuity (DVA) test using a LogMAR chart. Patient reads smallest line possible while head is stationary (static VA). Then patient rotates head horizontally at 2Hz while reading. Number of lines lost between static and dynamic conditions is recorded. Normal VOR: 1-2 lines lost. Abnormal: 4-6 lines lost. Higher lines lost = worse VOR function.

    Measured: Baseline (Week 0), Week 2, Week 4

  2. Change in Cybersickness Severity

    Measured by the Simulator Sickness Questionnaire (SSQ). Contains 16 symptoms rated 0-3 (0=not at all, 3=severe). Total score range 0-48. Subscales: Nausea (symptoms 1,2,6,7,8,9,14,15), Oculomotor (3,4,5,10,11,12,13), and Disorientation (5,10,11,12,13,14,15). Higher score = worse cybersickness.

    Measured: Baseline (Week 0), Week 2, Week 4

Secondary outcomes (1)
  1. Change in Quality of Life

    Measured by the Short Form-36 (SF-36) Health Survey. Contains 36 items measuring 8 domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, Mental Health. Scores transformed to 0-100 scale per domain. Higher score = better quality of life.

    Measured: Baseline (Week 0), Week 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2026
  2. Study start1 Jan 2026
  3. Primary completion10 May 2026
  4. Study completion22 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07616596
Sponsor's protocol ID
TUF/EIRB/ 211 /26
Acronym
GAZE-CS
Status last verified
Sep 2026
First submitted
23 May 2026
Last updated
10 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Gaze Stabilization Exercises and Oculomotor Exercises in people with Cybersickness and Motion Sickness, run by University of Faisalabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Vestibulo-Ocular Reflex (VOR) Function (time frame: Baseline (Week 0), Week 2, Week 4). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in